| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.84▲ | 2.79▲ | 2.80▲ | 2.87▲ | 2.99▲ |
| MA10 | 2.79▲ | 2.78▲ | 2.82▲ | 2.90▲ | 2.63▲ |
| MA20 | 2.80▲ | 2.89▲ | 2.94▲ | 2.89▲ | 2.49▲ |
| MA50 | 2.96▲ | 2.99▲ | 2.90▲ | 2.55▲ | 2.96▲ |
| MA100 | 2.86▲ | 2.68▲ | 2.57▲ | 2.45▲ | 3.40▼ |
| MA200 | 2.57▲ | 2.51▲ | 2.43▲ | 3.00▲ | 4.03▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.034▲ | 0.005▲ | -0.014▼ | -0.012▼ | 0.127▲ |
| RSI | 66.703▲ | 60.851▲ | 58.627▲ | 61.736▲ | 54.890▲ |
| STOCH | 50.265 | 26.063 | 21.234 | 30.458 | 66.099 |
| WILL %R | 0.000▲ | 0.000▲ | -25.000▲ | -22.308▲ | -23.264▲ |
| CCI | 271.694▲ | 168.156▲ | 77.206 | 76.367 | 127.430▲ |
|
Thursday, March 12, 2026 10:02 PM
FRAMINGHAM, MA / ACCESS Newswire / March 13, 2026 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology ...
|
|
Thursday, December 11, 2025 09:11 AM
FRAMINGHAM, MA / ACCESS Newswire / December 11, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/04/26 | 3.1187 | 3.19 | 2.9794 | 3.155 | 12,469 |
| 02/04/26 | 2.79 | 3.08 | 2.70 | 3.01 | 12,269 |
| 01/04/26 | 2.79 | 2.88 | 2.7416 | 2.82 | 7,040 |
| 31/03/26 | 2.72 | 2.79 | 2.66 | 2.68 | 8,315 |
| 30/03/26 | 2.75 | 2.755 | 2.65 | 2.67 | 11,907 |
| 27/03/26 | 2.77 | 2.805 | 2.72 | 2.72 | 15,091 |
| 26/03/26 | 2.94 | 2.9842 | 2.77 | 2.80 | 13,234 |
| 25/03/26 | 3.02 | 3.02 | 2.95 | 2.99 | 12,162 |
| 24/03/26 | 3.03 | 3.085 | 2.96 | 2.99 | 9,618 |
| 23/03/26 | 3.30 | 3.30 | 2.9748 | 3.13 | 11,666 |
|
|
||||
|
|
||||
|
|